{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:03:30Z","timestamp":1791169410815,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T00:00:00Z","timestamp":1339891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00432-012-1247-6","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T21:10:44Z","timestamp":1342213844000},"page":"1753-1758","source":"Crossref","is-referenced-by-count":6,"title":["HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents"],"prefix":"10.1007","volume":"138","author":[{"given":"Emmanuelle","family":"Tavernier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Flandrin-Gresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Solly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Rigollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Augeul-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Montmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Viallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Guyotat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,17]]},"reference":[{"key":"1247_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennet","year":"1976","unstructured":"Bennet JM, Catovsky D, Daniel MT et al (1976) Proposals for the classification of the acute leukaemias: French-American-British (FAB) cooperative group. Br J Haematol 33:451\u2013458","journal-title":"Br J Haematol"},{"issue":"3","key":"1247_CR2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12192-008-0035-3","volume":"13","author":"P Flandrin","year":"2008","unstructured":"Flandrin P, Guyotat D, Duval A, Cornillon J, Tavernier E, Nadal N, Campos L (2008) Significance of heat-shock protein (HSP90) expression in acute myeloid leukemia cells. Cell Stress Chaperones 13(3):357\u2013364","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"1247_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10549-011-1866-7","volume":"131","author":"EM Gartner","year":"2012","unstructured":"Gartner EM, Silverman P, Simon M, Flaherty L, Abrams J, Ivy P, Lorusso PM (2012) A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced unresectable breast cancer. Breast Cancer Res Treat 131(3):933\u2013937","journal-title":"Breast Cancer Res Treat"},{"key":"1247_CR4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.2005.09.119","volume":"23","author":"MP Goetz","year":"2005","unstructured":"Goetz MP, Toft DO, Reid JM, Ames M, Stensgard B, Safgren S, Adjei AA, Sloan J, Atherton P, Vasile V, Salazaar S, Adjei A, Croghan G, Erlichman C (2005) A phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol 23:1078\u20131087","journal-title":"J Clin Oncol"},{"issue":"3","key":"1247_CR5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1203\/01.PDR.0000153871.45184.19","volume":"57","author":"LM Hawkins","year":"2005","unstructured":"Hawkins LM, Jayanthan AA, Narendran A (2005) Effects of 17 AAG on pediatric acute lymphoblastic leukemia (ALL) with respect to Bcr-Abl status and imatinib mesylate sensitivity. Pediatr Res 57(3):430\u2013437","journal-title":"Pediatr Res"},{"issue":"11","key":"1247_CR6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3324\/haematol.2011.049551","volume":"96","author":"SH Kaufmann","year":"2011","unstructured":"Kaufmann SH, Karp JE, litzow MR, Mesa RA, Hogan W, Steensma DP, Flatten KS, Loegering DA, Schneider PA, Maurer MJ, Smith BD, Peterson KL, Greer J, Chen Y, Reid JM, Ivy Sp, Ames MM, Adjei AA, Erlichman C, Karnitz LM (2011) Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory leukaemia. Haematologica 96(11):1619\u20131626","journal-title":"Haematologica"},{"issue":"4","key":"1247_CR7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/leu.2009.292","volume":"24","author":"JE Lancet","year":"2010","unstructured":"Lancet JE, Gojo I, Burton M, Quinn M, Tighe SM, Kersey K, Zhong Z, Albitar MX, Bhalla K, Hannah AL, Baer MR (2010) Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022,17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia 24(4):699\u2013705","journal-title":"Leukemia"},{"key":"1247_CR8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.ge.22.120188.003215","volume":"22","author":"S Lindquist","year":"1988","unstructured":"Lindquist S, Craig EA (1988) The heat shock proteins. Annu Rev Genet 22:631\u2013677","journal-title":"Annu Rev Genet"},{"issue":"2","key":"1247_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2009.09.006","volume":"290","author":"Z Lu","year":"2010","unstructured":"Lu Z, Jin Y, Qiu L, Lai Y, Pan J (2010) Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. Cancer Lett 290(2):182\u2013191","journal-title":"Cancer Lett"},{"issue":"3","key":"1247_CR10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.urology.2011.04.041","volume":"78","author":"WK Oh","year":"2011","unstructured":"Oh WK, Galsky MD, Stadler WM, Srinivas S, Chu F, Bubley G, Goddard J, Dunbar J, Ross RW (2011) Multicenter phase II trial of the heat shock protein 90 inhibitor, retaspimycin hydrochloride (IPI-504), in patients with castration-resistant prostate cancer. Urology 78(3):626\u2013630","journal-title":"Urology"},{"issue":"2","key":"1247_CR11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2006-10-054098","volume":"110","author":"C Peng","year":"2007","unstructured":"Peng C, Brain J, Goodrich A, Kong L, Grayzel D, Pak R, Read M, Li S (2007) Inhibition of heat shock protein 90 prolongs survival of mice with Bcr-Abl-T315I-induced leukaemia and suppresses leukemic stem cells. Blood 110(2):678\u2013685","journal-title":"Blood"},{"issue":"7","key":"1247_CR12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.leu.2403764","volume":"19","author":"A Radujkovic","year":"2005","unstructured":"Radujkovic A, Schad M, Topaly J, Veldwijk MR, Laufs S, Schultheis BS, Jauch A, Melo JV, Fruehauf S, Zeller WJ (2005) Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL- inhibition of P-glycoprotein function by 17-AAG. Leukemia 19(7):1198\u20131206","journal-title":"Leukemia"},{"issue":"9","key":"1247_CR13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.leukres.2005.02.010","volume":"29","author":"X Thomas","year":"2005","unstructured":"Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le QH, Piselli S, Guyotat D (2005) Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res 29(9):1049\u20131058","journal-title":"Leuk Res"},{"issue":"6","key":"1247_CR14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s10637-010-9465-8","volume":"29","author":"WG Tong","year":"2010","unstructured":"Tong WG, Estrov Z, Wang Y, O\u2019Brien S, Faderl S, Harris DM, Van Pham Q, Hazan-Halevy I, Liu Z, Koch P, Kantarjian H, Keating MJ, Ferrajoli A (2010) The synthetic heat shock protein 90 (HSP90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukaemia cells. Invest New Drugs 29(6):1206\u20131212","journal-title":"Invest New Drugs"},{"issue":"18","key":"1247_CR15","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2009-10-249623","volume":"116","author":"F Tsukahara","year":"2010","unstructured":"Tsukahara F, Maru Y (2010) Bag1 directly routes immature BCR-ABL for proteasomal degradation. Blood 116(18):3582\u20133592","journal-title":"Blood"},{"issue":"7","key":"1247_CR16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/leu.2008.89","volume":"22","author":"LX Wu","year":"2008","unstructured":"Wu LX, Xu JH, Zhang KZ, Lin Q, Huang XW, Wen CX, Chen YZ (2008) Disruption of the Bcr-Abl\/HSP90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin. Leukemia 22(7):1402\u20131409","journal-title":"Leukemia"},{"issue":"2","key":"1247_CR17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.200104079","volume":"154","author":"JC Young","year":"2001","unstructured":"Young JC, Moarefi I, Hartl UF (2001) HSP 90: a specialized but essential protein-folding tool. J Cell Biol 154(2):267\u2013273","journal-title":"J Cell Biol"},{"issue":"6\u20137","key":"1247_CR18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0145-2126(92)90008-U","volume":"16","author":"Y Yufu","year":"1992","unstructured":"Yufu Y, Nishimura J, Nawata H (1992) High constitutive expression of heat shock protein 90 \u03b1 in human acute leukemia cells. Leuk Res 16(6\u20137):597\u2013605","journal-title":"Leuk Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1247-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-012-1247-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-012-1247-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:38Z","timestamp":1559083238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-012-1247-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,17]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["1247"],"URL":"https:\/\/doi.org\/10.1007\/s00432-012-1247-6","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,17]]}}}